Skip to content

Arsenicum Sulphuratum Flavum 3X as an adjunct to Individualized Homoeopathic Medicine in the treatment of Vitiligo

To assess the efficacy of Arsenicum Sulphuratum Flavum 3X as an adjunct to Individualized Homoeopathic Medicine in the treatment of Vitiligo:Double blind,double arm randomised controlled trial. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067563
Enrollment
80
Registered
2024-05-17
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

Intervention1: Arsenicum Sulphuratum Flavum 3X with Individualized Homoeopathic Medicine(IHM): IHM will be selected through the Kentian concept of symptom totality. And the potency selection, dose, r

Sponsors

Nehru Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. At least 1 vitiligo skin lesion measuring at least 2x2cm in size. 2. Subjects suffering from vitiligo for at least 03 months. 3. Providing written informed consent. 4. Patients using oral/topical agents for Vitiligo will be included after a washout period of two weeks. 5. Patients with known but controlled systemic diseases.

Exclusion criteria

Exclusion criteria: • Vitiligo universalis • Patients who are too sick for consultation and not willing to cooperate Unwilling to take part and not giving consent to join the study. • Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure. • Pregnant and Lactating women • Uncontrolled Diabetes, Hypertension, Mental illness or depression, kidney or heart disease • Substance abuse and/or dependence.

Design outcomes

Primary

MeasureTime frame
Vitiligo Area Scoring Index (VASI)Timepoint: At baseline and every month till one year

Secondary

MeasureTime frame
Vitiligo Quality of Life Index (VitiQoL) questionnaireTimepoint: At baseline and every month till one year

Countries

India

Contacts

Public ContactDrRashmi Chowdhry

Nehru Homoeopathic Medical College and Hospital

rashmichowdhry62@gmail.com9818366119

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026